NCT02631044 2024-06-27Study Evaluating the Safety and Pharmacokinetics of JCAR017 in B-cell Non-Hodgkin Lymphoma (TRANSCEND-NHL-001)Juno Therapeutics, a Subsidiary of CelgenePhase 1 Completed387 enrolled 2 FDA
NCT01009073 2017-11-20A Study Evaluating ABT-263 With Erlotinib, ABT-263 With Irinotecan, and ABT-263 Monotherapy in Cancer SubjectsAbbViePhase 1 Completed51 enrolled